GoodGut Overview
- Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
12
- Latest Deal Type
-
M&A
GoodGut General Information
Description
Operator of a biotechnological company intended to enhance the digestive health of patients. The company specializes in the development of tools for pre-diagnosis of early-stage colorectal cancer, irritable bowel syndrome and intestinal diseases to eliminate the need for conducting colonoscopy, enabling hospitals to maintain the digestive health of patients and provide treatment of digestive diseases based on intestinal microbiota.
Contact Information
Website
www.goodgut.eu
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Parent Company
Primary Office
- Edifici Center d'Empreses-Giroemprèn
- Calle Pic de Peguera, 11
- 17003 Girona
- Spain
+34 972 00 00 00
GoodGut Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 10-Sep-2021 | 00.000 | Completed | Clinical Trials - General | ||
| 6. Equity Crowdfunding | 12-Sep-2019 | 00000 | 00.000 | 00.000 | Completed | Clinical Trials - General |
| 5. Later Stage VC | 28-Jun-2019 | 00.000 | Completed | Clinical Trials - General | ||
| 4. Early Stage VC | 22-May-2018 | 00000 | 00.000 | 00.000 | Completed | Clinical Trials - General |
| 3. Early Stage VC | 27-Jan-2016 | 00000 | 00.000 | Completed | Clinical Trials - General | |
| 2. Early Stage VC | 12-Oct-2015 | $1.01M | $1.26M | 00.000 | Completed | Startup |
| 1. Capitalization | 01-Jan-2014 | $252K | $252K | Completed | Startup |
GoodGut Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
GoodGut Patents
GoodGut Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2018278276-A1 | Grape skin for use in the treatment of dysbiosis | Pending | 02-Jun-2017 | 000000000 | |
| EP-3630146-A1 | Grape skin for use in the treatment of dysbiosis | Pending | 02-Jun-2017 | 000000000 | |
| JP-2021130717-A | Grape skin for use in treatment of dysbiosis | Pending | 02-Jun-2017 | A61K36/87 |
GoodGut Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Mariona Serra-Pagès Ph.D | Co-Founder & Board Member | ||
| Xavier Aldeguer Ph.D | Co-Founder | ||
| Gabriel Masfuroll | Advisor |
GoodGut Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Jaume Amat | Self | Co-Founder, Board Member & Strategic Advisor | 000 0000 |
| Mariona Serra-Pagès Ph.D | GoodGut | Co-Founder & Board Member | 000 0000 |
GoodGut Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
GoodGut Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| BAGi | Angel Group | Minority | 000 0000 | 000000 0 | |
| Caixa Capital Risc | Venture Capital | Minority | 000 0000 | 000000 0 | |
| WA4STEAM | Angel Group | Minority | 000 0000 | 000000 0 |